Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Vaccine
|
November 2, 2013
Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours
M L Wumkes, A M T van der Velden, M Los, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 10, 2011
Response to influenza virus vaccination during chemotherapy in patients with breast cancer
A Meerveld-Eggink, O de Weerdt, A M T van der Velden, et al.
Bone Marrow Transplantation
|
February 16, 2016
Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study
M van Gelder, M H van Oers, W G Alemayehu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2020
Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study
M van der Meulen, K Bakunina, M Nijland, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2016
Diffuse large B-cell lymphoma with MYC gene rearrangements: Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature
A V de Jonge, T J A Roosma, I Houtenbos, et al.
Scientific Reports
|
July 3, 2023
The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies
K de Joode, W S van de Geer, G J L H van Leenders, et al.
Breast Cancer Research and Treatment
|
May 19, 2022
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature
M Opdam, V van der Noort, M Kleijn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 13, 2024
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial
M R Seefat, C A M Stege, B I Lissenberg-Witte, et al.
ESMO Open
|
March 7, 2024
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer
L W de Boo, K Jóźwiak, N D Ter Hoeve, et al.
Leukemia
|
January 31, 2024
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial
A A van de Loosdrecht, E M P Cremers, C Alhan, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Vaccine
|
November 2, 2013
Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours
M L Wumkes, A M T van der Velden, M Los, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 10, 2011
Response to influenza virus vaccination during chemotherapy in patients with breast cancer
A Meerveld-Eggink, O de Weerdt, A M T van der Velden, et al.
Bone Marrow Transplantation
|
February 16, 2016
Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study
M van Gelder, M H van Oers, W G Alemayehu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2020
Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study
M van der Meulen, K Bakunina, M Nijland, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2016
Diffuse large B-cell lymphoma with MYC gene rearrangements: Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature
A V de Jonge, T J A Roosma, I Houtenbos, et al.
Scientific Reports
|
July 3, 2023
The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies
K de Joode, W S van de Geer, G J L H van Leenders, et al.
Breast Cancer Research and Treatment
|
May 19, 2022
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature
M Opdam, V van der Noort, M Kleijn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 13, 2024
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial
M R Seefat, C A M Stege, B I Lissenberg-Witte, et al.
ESMO Open
|
March 7, 2024
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer
L W de Boo, K Jóźwiak, N D Ter Hoeve, et al.
Leukemia
|
January 31, 2024
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial
A A van de Loosdrecht, E M P Cremers, C Alhan, et al.
Page
of 2